Who has invested in ImmunOs Therapeutics?

Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, BioMed Partners, Redalpine are named among the investors backing ImmunOs Therapeutics.

ImmunOs Therapeutics Funding: $89M Raised, Series B (2022)

ImmunOs Therapeutics funding overview

ImmunOs Therapeutics is based in Schlieren, Switzerland. ImmunOs Therapeutics has raised $89M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2022. The round record for ImmunOs Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, BioMed Partners, Redalpine and 5 others. 11 distinct backers are named across the disclosed rounds.

ImmunOs Therapeutics at a glance

Total raised: $89M
Latest round: Series B
Latest round date: January 2022
Headquarters: Schlieren, Switzerland
Notable investors: Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, BioMed Partners, Redalpine, Schroder Adveq, Mission BioCapital

Frequently asked about ImmunOs Therapeutics funding

How much has ImmunOs Therapeutics raised?: ImmunOs Therapeutics has raised $89M in total disclosed funding across the rounds on record.
Who has invested in ImmunOs Therapeutics?: Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, BioMed Partners, Redalpine are named among the investors backing ImmunOs Therapeutics.
What was the latest ImmunOs Therapeutics funding round?: The most recent disclosed round is a Series B, announced in January 2022.
Where is ImmunOs Therapeutics based?: ImmunOs Therapeutics is based in Schlieren, Switzerland.
When did ImmunOs Therapeutics last raise?: The last disclosed ImmunOs Therapeutics round closed in January 2022 at Series B.

We update the ImmunOs Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Schlieren and their backers are listed below.

ImmunOs Therapeutics Funding: $89M Raised, Series B (2022)

ImmunOs Therapeutics funding overview

ImmunOs Therapeutics at a glance

Frequently asked about ImmunOs Therapeutics funding

Companies related to ImmunOs Therapeutics (23)

Browse related funding lists (6)